Adaptimmune Therapeutics News and Activities

Adaptimmune Therapeutics is a company listed under the stock ticker ADAP (US).

View the org chart displaying its 37 main executives

Gavin Wood, Chief Financial Officer, will leave the company on May 31, 2025 (posted on December 20 2024).
Helen Tayton-Martin, Chief Business Officer, will leave the company on Mar. 31, 2025 (posted on December 20 2024).

Create your alert
to follow the executive moves at Adaptimmune Therapeutics.

Regeneron Pharmaceuticals has announced the acquisition of 23andMe (posted on May 20 2025).
Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Customized Data Solutions

Executives

Companies

The Official Board